Company page
Genfit Sa
Genfit SA is a public company based in France, trading under the ticker GNFT. The company has a market capitalization of approximately €593.4 million. Genfit focuses on developing innovative therapeutic solutions and diagnostic tools for metabolic diseases, particularly non-alcoholic steatohepatitis (NASH).
- Ticker
- GNFT:EURONEXT
- Asset type
- Stock
- Market cap
- $593.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- EURONEXT
- Currency
- EUR